Joseph P. Pellegrino JR - 04 Dec 2025 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Director
Signature
/s/ Laurie A. Churchill, Attorney-in-fact
Issuer symbol
LMAT
Transactions as of
04 Dec 2025
Transactions value $
$0
Form type
4
Filing time
08 Dec 2025, 20:25:18 UTC
Previous filing
03 Dec 2025
Next filing
10 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pellegrino Joseph P JR Director C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON /s/ Laurie A. Churchill, Attorney-in-fact 08 Dec 2025 0001365733

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $0 +3 +0.03% $0.00 9.57K 06 Dec 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Dividend Equivalent Rights Award $0 +1.56 +6.13% $0.00 26.9 04 Dec 2025 Common Stock 1.56 Direct F2
transaction LMAT Dividend Equivalent Rights Award $0 +3.17 +9.11% $0.00 38 04 Dec 2025 Common Stock 3.17 Direct F3
transaction LMAT Dividend Equivalent Rights Award $0 +3.17 +9.29% $0.00 37.3 04 Dec 2025 Common Stock 3.17 Direct F4
transaction LMAT Dividend Equivalent Rights Award $0 +4.06 +15.7% $0.00 30 04 Dec 2025 Common Stock 4.06 Direct F5
transaction LMAT Dividend Equivalent Rights Award $0 +4.87 +17.86% $0.00 32.1 04 Dec 2025 Common Stock 4.87 Direct F6
transaction LMAT Dividend Equivalent Rights Award $0 +3.92 +33.93% $0.00 15.5 04 Dec 2025 Common Stock 3.92 Direct F7
transaction LMAT Dividend Equivalent Rights Options Exercise $0 -3 -19.38% $0.00 12.5 06 Dec 2025 Common Stock 3 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F2 These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3 These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4 These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5 These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F6 These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F7 These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F8 These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.